Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy [Phase 2]
A Phase 2 trial comparing high-dose PPOIT and high-dose peanut OIT to low-dose peanut OIT for peanut allergy has been withdrawn; no results …
-
CLINICAL_TRIALS withdrawal · 2014-09-10Clinical Trial Update: Walnut Oral Immunotherapy for Tree Nut Allergy [NA]
A walnut oral immunotherapy trial for peanut and tree nut allergy has been withdrawn, with no recruitment ongoing.
-
CLINICAL_TRIALS withdrawal · 2012-07-23Clinical Trial Update: Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy [Phase 2]
Novartis' Phase 2 trial evaluating four doses of QGE031 in adults with peanut allergy has been withdrawn.